Teva Pharmaceutical SWOT Analysis, Competitors & USP

Teva Pharmaceutical

Parent Company

Teva Pharmaceutical

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

Live your life; We make quality healthcare accessible around the world

USP

They are largest generic drug maker in the world. They make quality healthcare accessible around the world

Teva Pharmaceutical STP

Segment

Generic , branded products and API

Target Group

Healthcare professionals & pharmacists.

Positioning

Teva is the largest generic manufacturing company. They specialize in development, manufacturing & marketing of branded and generic products.

Teva Pharmaceutical SWOT Analysis

Strengths

Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of Teva Pharmaceutical. Strengths are:

1. Teva has presence in 60 countries & employs over  46,000 well trained people

2. No.1 generic company in the world with substantial market share

3. Has broadest portfolio of over 1300 molecules in generics

4. Holds patent for world’s largest selling multiple sclerosis drug Copaxone
5. One of the 15 largest pharmaceutical companies worldwid

Weaknesses

Here are the weaknesses of Teva Pharmaceutical :

1. Discontinued production of major anesthetic drugs

2. Teva gets sustantial revenue from outside U.S which is subjected to macro-economic fluctuations

Opportunities

Following are the Opportunities of Teva Pharmaceutical :

1. Consolidation of  Taiyo acquisition

2. Increasing generic market

3. Patents of major drugs are on the verge of expiry

Threats

The threats of Teva Pharmaceutical are as mentioned :

1.Stringent marketing & manufacturing regulations

2. Disruption of global supply chain due to changing environment

3. More resourceful companies entering generics market

Teva Pharmaceutical Competition

Competitors

Below are the 4 main Teva Pharmaceutical competitors :

1. Abbott laboratories
2. Merck

3. Acadia pharmaceuticals

4. Bayer Group